Raily Aesthetic Medicine International Holdings Limited (HKG:2135)
Hong Kong · Delayed Price · Currency is HKD 0.1500
+0.0010 (0.67%)
Feb 13, 2026, 4:08 PM HKT
HKG:2135 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 166.47 | 199.34 | 189.38 | 164.52 | 188.37 | 164.55 | |
Revenue Growth (YoY) | -20.46% | 5.26% | 15.11% | -12.66% | 14.48% | -13.92% |
Cost of Revenue | 114.39 | 127.94 | 117.89 | 97.74 | 118.68 | 84.37 |
Gross Profit | 52.08 | 71.41 | 71.49 | 66.78 | 69.69 | 80.17 |
Selling, General & Admin | 81.48 | 89.47 | 92.39 | 85.17 | 89.26 | 70.1 |
Research & Development | 1.08 | 0.72 | 1.6 | 2 | - | - |
Other Operating Expenses | 0.09 | 0.09 | 0.03 | - | - | - |
Operating Expenses | 82.65 | 90.28 | 94.02 | 87.17 | 89.26 | 70.1 |
Operating Income | -30.57 | -18.87 | -22.52 | -20.39 | -19.57 | 10.07 |
Interest Expense | -2.63 | -2.81 | -2.8 | -2.8 | -2.42 | -2.44 |
Interest & Investment Income | 0.39 | 0.4 | 0.84 | 0.73 | 1.23 | 0.68 |
Earnings From Equity Investments | -0.1 | -0.08 | -1.74 | -0.16 | -0.15 | - |
Currency Exchange Gain (Loss) | - | - | 0.24 | 2.64 | - | - |
Other Non Operating Income (Expenses) | -48.33 | -62.44 | -16.4 | -6.49 | -3.12 | 2.39 |
EBT Excluding Unusual Items | -81.24 | -83.8 | -42.39 | -26.47 | -24.02 | 10.69 |
Gain (Loss) on Sale of Assets | 0.55 | 0.1 | 0.16 | - | - | - |
Other Unusual Items | 9.4 | 18.44 | 7.22 | 4.36 | 1.07 | 0.87 |
Pretax Income | -71.28 | -65.26 | -35.01 | -22.1 | -22.95 | 11.57 |
Income Tax Expense | -1.56 | -1.99 | 2.77 | -1.85 | -4.68 | 6.66 |
Earnings From Continuing Operations | -69.73 | -63.26 | -37.78 | -20.25 | -18.27 | 4.91 |
Minority Interest in Earnings | 4.56 | 4.05 | 5.32 | 4.34 | 0.58 | -0.66 |
Net Income | -65.17 | -59.21 | -32.46 | -15.91 | -17.69 | 4.25 |
Net Income to Common | -65.17 | -59.21 | -32.46 | -15.91 | -17.69 | 4.25 |
Net Income Growth | - | - | - | - | - | -57.05% |
Shares Outstanding (Basic) | 557 | 533 | 418 | 418 | 417 | 343 |
Shares Outstanding (Diluted) | 557 | 533 | 418 | 418 | 417 | 343 |
Shares Change (YoY) | 20.33% | 27.53% | - | 0.08% | 21.62% | 5.64% |
EPS (Basic) | -0.12 | -0.11 | -0.08 | -0.04 | -0.04 | 0.01 |
EPS (Diluted) | -0.12 | -0.11 | -0.08 | -0.04 | -0.04 | 0.01 |
EPS Growth | - | - | - | - | - | -59.34% |
Free Cash Flow | 4.53 | -2.64 | -9.98 | -21.13 | -18.23 | 5.82 |
Free Cash Flow Per Share | 0.01 | -0.01 | -0.02 | -0.05 | -0.04 | 0.02 |
Gross Margin | 31.28% | 35.82% | 37.75% | 40.59% | 37.00% | 48.72% |
Operating Margin | -18.37% | -9.47% | -11.89% | -12.39% | -10.39% | 6.12% |
Profit Margin | -39.15% | -29.70% | -17.14% | -9.67% | -9.39% | 2.58% |
Free Cash Flow Margin | 2.72% | -1.32% | -5.27% | -12.84% | -9.68% | 3.54% |
EBITDA | -14.9 | -1.53 | -7.03 | -7.05 | -11.58 | 17.48 |
EBITDA Margin | -8.95% | -0.77% | -3.71% | -4.29% | -6.15% | 10.63% |
D&A For EBITDA | 15.67 | 17.34 | 15.5 | 13.33 | 7.98 | 7.42 |
EBIT | -30.57 | -18.87 | -22.52 | -20.39 | -19.57 | 10.07 |
EBIT Margin | -18.37% | -9.47% | -11.89% | -12.39% | -10.39% | 6.12% |
Effective Tax Rate | - | - | - | - | - | 57.54% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.